BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9754638)

  • 21. Cardiovascular responses to microinjection of noradrenaline into the medial amygdaloid nucleus of conscious rats result from α₂-receptor activation and vasopressin release.
    Fortaleza EA; Scopinho AA; Corrêa FM
    Eur J Neurosci; 2011 May; 33(9):1677-84. PubMed ID: 21535246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional hemodynamic and baroreflex effects of endothelin in rats.
    Knuepfer MM; Han SP; Trapani AJ; Fok KF; Westfall TC
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H918-26. PubMed ID: 2675635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of posterior hypothalamic injection of neuropeptide Y in awake rats.
    Martin JR; Knuepfer MM; Westfall TC
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H814-24. PubMed ID: 1887927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin.
    Cornish JL; van den Buuse M
    Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pressor response to microinjection of clonidine into the hypothalamic paraventricular nucleus in conscious rats.
    Ebihara H; Kawasaki H; Nakamura S; Takasaki K; Wada A
    Brain Res; 1993 Oct; 624(1-2):44-52. PubMed ID: 7902772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic supraoptic but not paraventricular nucleus is involved in cardiovascular responses to carbachol microinjected into the bed nucleus of stria terminalis of unanesthetized rats.
    Alves FH; Crestani CC; Busnardo C; Antunes-Rodrigues J; Gomes FV; Resstel LB; Corrêa FM
    Brain Res; 2011 Jun; 1393():31-43. PubMed ID: 21466795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
    Dedeoğlu A; Fisher LA
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms involved in the pressor response to noradrenaline microinjection into the supraoptic nucleus of unanesthetized rats.
    Busnardo C; Tavares RF; Corrêa FM
    Auton Neurosci; 2009 Jan; 145(1-2):63-70. PubMed ID: 19059010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DMPP-evoked increases in postganglionic sympathetic nerve activity and blood pressure occurs by two mechanisms in the rat.
    Martin JR
    J Auton Pharmacol; 1997 Aug; 17(4):249-59. PubMed ID: 9373784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential role of hypothalamic muscarinic and alpha-adrenergic receptors in atrial natriuretic peptide release induced by blood volume expansion.
    Antunes-Rodrigues J; Marubayashi U; Favaretto AL; Gutkowska J; McCann SM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10240-4. PubMed ID: 8234284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
    Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
    J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the antimuscarinic effects of pirenzepine and N-methylatropine on ganglionic and vascular muscarinic receptors in the rat.
    Wess J; Lambrecht G; Moser U; Mutschler E
    Life Sci; 1984 Jul; 35(5):553-60. PubMed ID: 6379356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal muscarinic, glutamatergic and GABAergic receptor systems in cardiovascular regulation.
    Feldman DS; Buccafusco JJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):274-83. PubMed ID: 9103507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nicotinic receptor blockade inhibits emotionally conditioned pressor responses in rats.
    Kubo T; Katsumata Y; Fukumori R; Taguchi K; Hagiwara Y
    Experientia; 1996 Apr; 52(4):348-52. PubMed ID: 8620939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional haemodynamic effects of carbachol injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
    Bachelard H; Gardiner SM; Kemp PA; Bennett T
    Neuropharmacology; 1994 Jun; 33(6):769-88. PubMed ID: 7936115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus.
    Karanth S; Lyson K; McCann SM
    Neuroimmunomodulation; 1999; 6(3):168-74. PubMed ID: 10213914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat.
    Lazartigues E; Freslon JL; Tellioglu T; Brefel-Courbon C; Pelat M; Tran MA; Montastruc JL; Rascol O
    Eur J Pharmacol; 1998 Nov; 361(1):61-71. PubMed ID: 9851542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.